NYSE

Maximus, Inc. (MMS)

581 Thanks from members

Maximus, Inc. (MMS) exhibits mixed market sentiment following Q3 2026 results, characterized by solid margin expansion and raised EPS guidance balanced against headwinds from paused VA performance incentives and low book-to-bill ratios.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →